With an experience of +25 years in drug development, Health Economia Advisory provides you with guidance to inform your decisions, and a Development Studio to secure and accelerate the development of your assets.
We assist our customers in making well-informed decisions regarding the development and management of their assets. Our primary focus is on the buy side, where we provide expertise and guidance to ensure optimal investment choices and strategic development.
Scientific, medical and regulatory expertise to inform your decision making.
Let your asset’s team focus on the science, yet secure the performance of enabling activities to reach the next value inflection-point.
Introducing the Health Economia Advisory team, your premier advisors in the domain of drug development.
Specializing in guiding biotechs, board members, and supporting investors through the process of due diligence and portfolio company development, we leverage our deep industry knowledge and cutting-edge insights to propel your projects forward.
Subscribe now to receive the latest newsletter updates, access exclusive white papers, and let us know if you'd like to be contacted directly!
Stay updated with our latest news and publications
Why the 7.9% industry average is not a life sentence — and how to escape it Health Economia | White Paper | May 2026 Executive Summary Across all therapeutic areas and modalities, only approximately 1 in 13 drug…
Covering key developments between 1 November 2025 and 30 November 2025. European Medicines Agency (EMA) November’s CHMP meeting delivered ten positive opinions for new medicines and four indication extensions, with a continued focus on rare diseases, endocrine/metabolic disorders,…
European Medicines Agency (EMA) The CHMP endorsed the following positive opinions (initial approval or indication extension) in their October 2025 Session: The PRAC, in their 27-30 October session, endorsed a DHPC reinforcing Tranexamic acid injections IV-only use with stronger warnings and…
Don’t miss out on insights and updates that matter—dive into all our latest news and publications!
Scientific Back Office, Drug Development Studio
Health Economia GmbH © 2025
